MissionIR Articles
-
MissionIRNewsBreaks – Eloro Resources Ltd. (TSX.V: ELO) (OTCQX: ELRRF) (FSE: P2QM) CEO Featured in BTV Release Bolivia Project
Eloro Resources (TSX.V: ELO) (OTCQX: ELRRF) (FSE: P2QM), a leading exploration and mine development company, will be spotlighted in an upcoming BNN Bloomberg broadcast in Canada. The broadcast features BTV-Business Television interviews and will be aired on Dec. 2, 2023, at 8 p.m. ET and Dec. 3, 2023, at 4:30 p.m. ET. The interview will…
-
MissionIRNewsBreaks – Correlate Energy Corp. (CIPI) Announces Completion of Continental Envelope Solar Facility
Correlate Energy (OTCQB: CIPI), a growth-oriented distributed energy company, has completed construction of one of Illinois’ largest rooftop, solar-power facilities. The project is located at Continental Envelope’s manufacturing plant in Geneva, Illinois. A pioneering independent manufacturer of commercial envelopes since the 1930s, Continental Envelope produces some 2 billion envelopes a year and has clients that…
-
MissionIRNewsBreaks – Scinai Immunotherapeutics Ltd. (NASDAQ: SCNI) Announces Maturity Extension of EIB Finance Facility
Scinai Immunotherapeutics (NASDAQ: SCNI) today announced the execution of a formal amendment to its finance contract with the European Investment Bank (“EIB”). According to the announcement, the amendment extends the maturity date of the contract by four years from Dec. 31, 2027, to Dec. 31, 2031. “I thank the EIB for their ongoing support and…
-
MissionIRNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Proprietary Tech Lowers Blood Glucose More Effectively than Branded GLP-1 drug Semaglutide Alone, Study Shows
Lexaria Bioscience (NASDAQ: LEXX, LEXXW), a global innovator in drug-delivery platforms, is reporting additional positive interim results from its human pilot study evaluating DehydraTECH(TM) technology for the oral delivery of the glucagon-like peptide-1 (“GLP-1”) drug semaglutide, available commercially as Rybelsus(R). According to the report, DehydraTECH-powered semaglutide sustained lower levels of blood glucose from baseline including nearly 10…
-
MissionIRNewsBreaks – Lexaria Bioscience Corp.’s (NASDAQ: LEXX) DehydraTECH(TM) Shown to Improve Oral Performance of GLP-1 Drug in Human Pilot Study
Lexaria Bioscience (NASDAQ: LEXX, LEXXW), a global innovator in drug delivery platforms, today announced positive interim results from a human pilot study currently underway evaluating DehydraTECH(TM) technology for the oral delivery of the glucagon-like peptide-1 (“GLP-1”) drug semaglutide, which is available commercially in the branded product Rybelsus(R). A prominent university research center is performing the…
-
MissionIRNewsBreaks – Safety Shot (NASDAQ: SHOT) Begins Scientific Study, Hires Securities Litigation Attorney
Safety Shot (NASDAQ: SHOT), a wellness and functional beverage company, has begun a double-blind, placebo-controlled clinical trial designed to study and evaluate the effects of its flagship product, Safety Shot, on blood and breath alcohol levels. According to the announcement, the company is committed to the scientific development of Safety Shot, the first patented beverage…
-
MissionIRNewsBreaks – Mullen Automotive Inc. (NASDAQ: MULN) Issues Update on CBP Application for Class 1 EV Cargo Vans
Mullen Automotive (NASDAQ: MULN), an emerging electric vehicle (“EV”) manufacturer, today announced that the company and Rapid Response Defense Systems (“RRDS”) have filed responses for final ruling and compliance by the U.S. Customs and Border Protection (“CBP”) application for Mullen’s Class 1 EV cargo van. In March 2023, the companies announced a partnership with RRDS,…
-
MissionIRNewsBreaks – Safety Shot Inc. (NASDAQ: SHOT) Issues Warning to Shareholders
Safety Shot (NASDAQ: SHOT) today announced that it has come to its attention that there are several disclosed short sellers publishing malicious defamatory, inaccurate articles about Safety Shot and its management in a willful attempt to scare SHOT investors out of their positions in hopes of getting them to sell their shares so they can…
-
MissionIRNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Presents Updated Safety Data from Berubicin Study at SNO Annual Gathering
CNS Pharmaceuticals (NASDAQ: CNSP), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers in the brain and central nervous system, has announced the presentation of updated safety data from its ongoing potentially pivotal study evaluating Berubicin. According to the announcement, the data showed the comparability of the patient demographics in…
-
MissionIRNewsBreaks – Renovaro BioSciences Inc. (NASDAQ: RENB) Poised to Spearhead Advancements in Battle Against Diseases, Harness Cutting-Edge AI Technology
Renovaro BioSciences (NASDAQ: RENB), an advanced, pre-clinical biotechnology firm in cell, gene and immunotherapy, recently announced a definitive agreement to combine with the advanced AI company GEDiCube International Ltd, rebranding as Renovaro AI. “The company has also announced the addition of three new members to its board of directors – Avram Miller, Leni Boeren and…
-
MissionIRNewsBreaks – Turbo Energy S.A. (NASDAQ: TURB) GM Featured Guest on Latest Bell2Bell Podcast Release
Turbo Energy S.A. (NASDAQ: TURB), a leading photovoltaic energy-storage technology company based in Valencia, Spain, is featured in a recent episode of IBN’s The Bell2Bell Podcast. According to the announcement, Turbo Energy general manager Mariano Soria joined host Stuart Smith to discuss the company and its business model, as well as the renewable energy space…
-
MissionIRNewsBreaks – Safety Shot Inc. (NASDAQ: SHOT) Set for Dec. 7 California Launch
Safety Shot (NASDAQ: SHOT) today announced the west coast launch of Safety Shot, the first patented beverage on Earth that helps people feel better faster by reducing blood alcohol content and boosting clarity. Safety Shot is a nutraceutical functional beverage, created by industry experts and validated by research, that accelerates the body’s break-down of alcohol…
-
MissionIRNewsBreaks – PaxMedica Inc. (NASDAQ: PXMD) Announces Pricing of $7M Public Offering
PaxMedica (NASDAQ: PXMD), a biopharmaceutical company focused on advancing treatments for neurological disorders, today announced the pricing of its public offering of an aggregate of 5,384,615 shares of its common stock (or common stock equivalents in lieu thereof) and warrants to purchase up to 5,384,615 shares of common stock, at a combined public offering price…
-
MissionIRNewsBreaks – Eloro Resources Ltd. (TSX: ELO) (OTCQX: ELRRF) (FSE: P2QM) Expands on Iska Iska’s Potential
Eloro Resources (TSX: ELO) (OTCQX: ELRRF) (FSE: P2QM), an exploration and mining company, recently filed its NI43-101 technical report for its Iska Iska Polymetallic Property in support of its initial mineral resource estimate (“MRE”) published earlier. The company opted to employ the net smelter return (“NSR”) method to encompass the estimated dollar value that each…
-
MissionIRNewsBreaks – FingerMotion Inc. (NASDAQ: FNGR) Releases Update on Federal Lawsuit Filed Against Research Firm
FingerMotion (NASDAQ: FNGR), a mobile services and data company, is reporting an update on the federal lawsuit it filed against Capybara Research last month; the lawsuit alleges that Capybara maliciously published a defamatory article in a premediated attempt to move the public market for FingerMotion’s stock lower to benefit from its previously announced short position.…
-
MissionIRNewsBreaks — Mullen Automotive Inc. (NASDAQ: MULN) Partner Receives Key Retail License, Begins Shipping EVs
Mullen Automotive (NASDAQ: MULN), an emerging electric vehicle (“EV”) manufacturer, announced that its partner, the Randy Marion Automotive Group (“RMA”), has received its North Carolina license to retail Mullen’s commercial EVs. According to the announcement, this is a required dealer license that allows the auto group to move vehicles to customers. According to RMA officials,…
-
MissionIRNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) to Release Interim Data by Year End for Lead Treatment Candidate Berubicin
CNS Pharmaceuticals (NASDAQ: CNSP) is a biopharmaceutical company focused on developing innovative therapies for central nervous system disorders, specifically aggressive brain cancers. The company today announced its confidence in sharing the results from an interim analysis on one of its lead treatment candidates, Berubicin, with the public before the end of the year. Berubicin is…
-
MissionIRNewsBreaks – NextPlat Corp.’s (NASDAQ: NXPL) Strong Growth Featured in Proactive Podcast
NextPlat (NASDAQ: NXPL, NXPLW), a global e-commerce provider, was featured in an interview with Proactive, where its CEO Charlie Fernandez joined host Steve Darling to provide an update on the company’s latest financial results. NextPlat has made impressive strides in consolidating its global e-commerce and Progressive Care health care operations, leading to significant growth. During…
-
MissionIRNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Continues to Advance Patented DehydraTECH(TM)
Lexaria Bioscience Corp. (NASDAQ: LEXX), a global innovator in drug delivery platforms, is steadily advancing its patented DehydraTECH(TM) technology for a growing range of applications including oral nicotine, hypertension, antivirals, human hormone therapy, diabetes and more. Through previous clinical trials, DehydraTECH-processed CBD has shown its ability to lower blood pressure in patients over multiple weeks.…
-
MissionIRNewsBreaks — SenesTech Inc. (NASDAQ: SNES) to Effect Reverse Stock Split
SenesTech (NASDAQ: SNES), the leader in fertility control to manage animal pest populations, today announced that it intends to effect a reverse stock split of its common stock at a ratio of 1 post-split share for every 12 pre-split shares. According to the announcement, the reverse stock split will become effective at 4:01 p.m., Eastern…
Search Articles
Latest Articles
- MissionIRNewsBreaks – Soligenix Inc. (NASDAQ: SNGX) Publishes Positive HyBryte Study Results In Oncology and Therapy
- Ucore Rare Metals Inc. (TSX.V: UCU) (OTCQX: UURAF) Strengthens Position amid Global REE Supply Challenges
- MissionIRNewsBreaks – Datavault AI Inc. (NASDAQ: DVLT) Partners With Demora Foundation To Power K-Entertainment Tokenization Platform
- MissionIRNewsBreaks – CMX Gold & Silver Corp. (CSE: CXC) (OTC: CXXMF) Explores Multi-Vein Potential at Idaho Clayton Project
- MissionIRNewsBreaks – Massimo Group (NASDAQ: MAMO) Reports 2025 Results, Expands Margins Amid Strategic Shift